Published in Blood on May 15, 2000
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet (2001) 9.34
Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell (2007) 2.92
Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. Immunity (2011) 2.69
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci U S A (2006) 2.59
Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One (2008) 2.33
Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A (2003) 2.30
Colchicine: old and new. Am J Med (2014) 2.05
Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum (2009) 2.02
Human TRIM gene expression in response to interferons. PLoS One (2009) 1.84
NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol (2007) 1.73
The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet (2001) 1.68
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol (2009) 1.46
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol (2010) 1.45
Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr (2003) 1.27
The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood (2008) 1.27
Familial Mediterranean fever. Pediatr Nephrol (2003) 1.16
The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med (2004) 1.15
Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis (2005) 1.04
Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther (2007) 1.02
Inflammasomes and their activation. Crit Rev Immunol (2010) 0.98
Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity. Protein Sci (2013) 0.96
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia (2013) 0.95
Familial Mediterranean fever responds well to infliximab: single case experience. Clin Rheumatol (2005) 0.95
Developments in the scientific and clinical understanding of autoinflammatory disorders. Arthritis Res Ther (2009) 0.91
Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol (2004) 0.91
Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction. J Immunol (2013) 0.90
Immunology in clinic review series; focus on autoinflammatory diseases: inflammasomes: mechanisms of activation. Clin Exp Immunol (2012) 0.90
Francisella Recognition by Inflammasomes: Differences between Mice and Men. Front Microbiol (2011) 0.90
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med Genomics (2009) 0.89
Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature. Pediatr Nephrol (2005) 0.88
The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ (2011) 0.88
Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1β levels. PLoS One (2012) 0.88
Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. Open Cardiovasc Med J (2010) 0.87
Clinical immunology review series: An approach to the patient with a periodic fever syndrome. Clin Exp Immunol (2011) 0.86
Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly. J Biol Chem (2014) 0.86
Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition. PLoS One (2008) 0.85
Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol (2006) 0.85
The PYRIN domain in signal transduction. Curr Protein Pept Sci (2007) 0.85
Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor. Eur Biophys J (2009) 0.84
Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int (2007) 0.84
The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self. Semin Immunopathol (2007) 0.83
1Novel MEFV transcripts in Familial Mediterranean fever patients and controls. BMC Med Genet (2010) 0.81
Decreased vitamin D levels in patients with familial mediterranean fever. Rheumatol Int (2011) 0.80
Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases? Clin Exp Immunol (2009) 0.80
TLR polymorphisms in FMF: association of TLR-2 (Arg753Gln) and TLR-4 (Asp299Gly, Thre399Ile) polymorphisms and myeloid cell TLR-2 and TLR-4 expression with the development of secondary amyloidosis in FMF. Inflammation (2011) 0.80
Vascular comorbidities in familial Mediterranean fever. Rheumatol Int (2011) 0.80
Association between MEFV Mutations M694V and M680I and Behçet's Disease: A Meta-Analysis. PLoS One (2015) 0.80
The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach. PLoS One (2013) 0.79
Non-canonical manifestations of familial Mediterranean fever: a changing paradigm. Clin Rheumatol (2015) 0.79
Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters. Rheumatol Int (2008) 0.79
Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever. Front Microbiol (2016) 0.78
Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis. Eur J Pediatr (2012) 0.78
Carbon monoxide decreases interleukin-1β levels in the lung through the induction of pyrin. Cell Mol Immunol (2015) 0.77
Accelerated apoptosis of neutrophils in familial mediterranean Fever. Front Immunol (2015) 0.76
The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever. Rheumatol Int (2006) 0.76
Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes. Comput Math Methods Med (2015) 0.76
High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia. Indian J Hematol Blood Transfus (2011) 0.76
TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever. Clin Rheumatol (2014) 0.76
Decreased prevalence of atopy in paediatric patients with familial Mediterranean fever. Ann Rheum Dis (2004) 0.76
Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis. Orphanet J Rare Dis (2015) 0.75
Genetic and Epigenetic Determinants in Autoinflammatory Diseases. Front Immunol (2017) 0.75
Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter. Open Rheumatol J (2011) 0.75
Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case-control study. Neuropsychiatr Dis Treat (2016) 0.75
Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever. Orphanet J Rare Dis (2015) 0.75
The MEFV gene pathogenic variants and phenotype-genotype correlation in children with familial Mediterranean fever in the Çanakkale population. Balkan J Med Genet (2017) 0.75
The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever. Eur J Rheumatol (2016) 0.75
Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease. Mediators Inflamm (2006) 0.75
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. Front Immunol (2017) 0.75
Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture models. Genet Mol Biol (2017) 0.75
New insights into the epigenetics of inflammatory rheumatic diseases. Nat Rev Rheumatol (2017) 0.75
Jaks and STATs: biological implications. Annu Rev Immunol (1998) 7.18
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Positive Darwinian selection after gene duplication in primate ribonuclease genes. Proc Natl Acad Sci U S A (1998) 5.54
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Effects of sampling standardization on estimates of Phanerozoic marine diversification. Proc Natl Acad Sci U S A (2001) 5.27
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A (2001) 4.76
Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) (2000) 4.45
The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med (1995) 4.25
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17
Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet (1998) 3.93
Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene (2009) 3.90
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (1995) 3.43
Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet (1997) 3.39
Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol (1977) 3.33
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature (1994) 3.31
Current concepts: immunology. Neutrophils in human diseases. N Engl J Med (1987) 3.29
Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol (1985) 3.02
Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem (1987) 2.99
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93
Ultrasound therapy for calcific tendinitis of the shoulder. N Engl J Med (1999) 2.92
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med (2001) 2.75
NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest (2000) 2.67
Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest (1998) 2.67
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis (1998) 2.53
Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A (1995) 2.52
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science (1989) 2.39
Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes. Proc Natl Acad Sci U S A (1999) 2.39
Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods (1995) 2.35
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. Science (1992) 2.31
Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev (2000) 2.29
Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J Immunol (1986) 2.28
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol (2001) 2.24
Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol (2008) 2.23
Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med (1998) 2.21
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet (1999) 2.19
IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol (2001) 2.13
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood (1996) 2.12
A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry (1995) 2.12
Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood (2000) 2.09
Chromatin boundaries and chromatin domains. Cold Spring Harb Symp Quant Biol (2004) 2.08
Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology (1991) 2.05
Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) (1998) 2.03
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J Immunol (2000) 2.01
Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science (1988) 2.00
The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis. Aliment Pharmacol Ther (2013) 1.98
Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg (1998) 1.95
Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet (1998) 1.95
Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest (1996) 1.94
Randomized clinical trial of supportive follow-up for cigarette smokers in a family practice. Can Med Assoc J (1982) 1.94
Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med (1989) 1.93
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Viral infections in interferon-gamma receptor deficiency. J Pediatr (1999) 1.91
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med (1992) 1.90
Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. Infect Immun (2000) 1.87
Occluded Portex Epifuse™ epidural connector. Anaesthesia (2012) 1.87
Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge. Nat Immunol (2000) 1.84
The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood (2001) 1.84
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev (1999) 1.83
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid (1999) 1.81
Determining growth rates of focal lesions of bone from radiographs. Radiology (1980) 1.81
Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol (2001) 1.81
gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol (2000) 1.80
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med (1995) 1.78
The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol (2000) 1.75
Interactions between antibiotics and human neutrophils in the killing of staphylococci. J Clin Invest (1981) 1.74
Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med (1999) 1.73
Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci (1994) 1.70
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol (1996) 1.68